2. Signaling Pathways
  3. PI3K/Akt/mTOR
  4. PI3K
  5. PI3K Isoform
  6. PI3K Control

PI3K Control

PI3K Controls (4):

Cat. No. Product Name Effect Purity
  • HY-156681A
    (S)-STX-478
    		Control 99.18%
    (S)-STX-478 is the S-enantiomer of STX-478. STX-478 is a selective inhibitor of PI3Kα mutants, preventing metabolic dysfunction and demonstrating antitumor activity in xenograft mouse models with PI3Kα mutant tumors.
  • HY-12481A
    SAR405 R enantiomer
    		Control 99.94%
    SAR405 R enantiomer is the less active enantiomer of SAR405. SAR405 is a PIK3C3/Vps34 inhibitor.
  • HY-108418A
    (R)-PI3Kδ-IN-15
    		Control 99.52%
    (R)-PI3Kδ-IN-15 is the R-enantiomer of PI3Kδ-IN-15 (HY-108418).
  • HY-153306A
    (S)-RLY-2608
    		Control
    (S)-RLY-2608 is an S-enantiomer of of RLY-2608 (HY-153306). RLY-2608 is an orally active first-in-class allosteric mutant-selective inhibitor of PI3Ka with anti-tumor activity.